Patent 11180512 was granted and assigned to Qpex Biopharma on November, 2021 by the United States Patent and Trademark Office.
Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).